Related Experiment Videos
Short-course antibiotic therapy for infections with a single causative pathogen
1Department of Antimicrobial Therapy and Infectious Diseases, Dr von Haunersches Children's Hospital, Ludwig-Maximilians University, Munich, Germany.
The Journal of International Medical Research
|November 25, 2000
Summary
Short-course antibiotic therapy, including 5-day cefuroxime axetil for otitis media and 4-5 day cephalosporins for tonsillopharyngitis, shows promising results. These shorter regimens offer comparable or improved efficacy with better tolerability and compliance.
Area of Science:
- Infectious Diseases
- Pharmacology
- Clinical Medicine
Background:
- Short-course antibiotic therapy is being explored for common infections.
- Previous studies focused on infections with clear etiological origins.
Purpose of the Study:
- To evaluate the efficacy and tolerability of short-course antibiotic regimens.
- To compare short-course cephalosporins with standard penicillin V for tonsillopharyngitis.
- To assess short-course cephalosporins for acute bacterial exacerbations of chronic bronchitis.
Main Methods:
- Meta-analyses of clinical trials were conducted.
- Comparison of 5-day cefuroxime axetil for acute otitis media.
- Evaluation of 4-5 day oral cephalosporin courses versus 10-day penicillin V for tonsillopharyngitis.
- Assessment of short-course versus standard-course cephalosporins for chronic bronchitis exacerbations.
Main Results:
- Uncomplicated acute otitis media in children successfully treated with 5-day cefuroxime axetil.
- Short-course cephalosporins showed higher clinical cure and bacteriological eradication rates than penicillin V for tonsillopharyngitis.
- Bacteriological failure rates were halved with cephalosporins compared to penicillin V.
- No difference in clinical cure or relapse rates for chronic bronchitis exacerbations between short-course and standard-course cephalosporins.
- Short courses demonstrated improved gastrointestinal tolerance.
Conclusions:
- Short-course antibiotic dosing regimens are viable for prevalent infections.
- These regimens offer potential benefits including increased tolerability, reduced healthcare costs, and enhanced patient compliance.
- Short-course therapy may aid in controlling antibiotic resistance development.